143.50 @ Closing

Quote

anonymous

Guest
On Jan31 2014 the stock closed at $158.73.
On Feb1 2016 the stock closed at $143.50.

For sure the overall stock market is affecting the price here. The equity is what is/has kept a lot of people from leaving. It's what historically made people from putting up with accelerated dog-years aging, constant fire drills around net stops, no family life, and dysfunctional management.
 






anonymous said:
On Jan31 2014 the stock closed at $158.73.
On Feb1 2016 the stock closed at $143.50.

For sure the overall stock market is affecting the price here. The equity is what is/has kept a lot of people from leaving. It's what historically made people from putting up with accelerated dog-years aging, constant fire drills around net stops, no family life, and dysfunctional management.
Click to expand...

The Biotech market itself has been hit harder than most segments (other than oil stocks).

With that said, there is a bit of a bright side. With the current drop, the new equity grants will be at a lower strike price.
 












PSU's
Again, rewarding only those at the top in geographies that support the numbers....what about rewarding at other levels for incremental improvements in territories that were under performing? Oh yeah, you need a manager that supports you. Hahahaha! Where is leadership in this churn & burn company?
 






You spoke too soon. $130/share now, same as 5 years ago. One thing the HR schills here can't deny, despite trying, is the entire sales leadership and marketing team have turned over entirely the past 2 years (...and 2 years before that). It's dog years in terms of aging, and the stagnant business performance/net-stops aren't helping with retention. The 'everybody has aHUS!' strategy isn't working.
 






anonymous said:
You spoke too soon. $130/share now, same as 5 years ago. One thing the HR schills here can't deny, despite trying, is the entire sales leadership and marketing team have turned over entirely the past 2 years (...and 2 years before that). It's dog years in terms of aging, and the stagnant business performance/net-stops aren't helping with retention. The 'everybody has aHUS!' strategy isn't working.
Click to expand...
The stock was way ahead of itself 2 to 3 years ago. Alexion still trades at a premium compared to other Biotechs. Over the last few months, our stock has dropped in line with the others. As for turnover, stop being a drama queen. There has not been a complete turnover. There has been the typical turnover like other companies as well as new heads from growth. Think twice before posting if you don't want to sound like a moron.
 






anonymous said:
The stock was way ahead of itself 2 to 3 years ago. Alexion still trades at a premium compared to other Biotechs. Over the last few months, our stock has dropped in line with the others. As for turnover, stop being a drama queen. There has not been a complete turnover. There has been the typical turnover like other companies as well as new heads from growth. Think twice before posting if you don't want to sound like a moron.
Click to expand...


STFU you moron.
(disclaimer: this is an anonymous message board. Don't call people names. State your case. Step to the left. Pay your money. Otherwise... No post for you! Come back, one year!)
 






anonymous said:
STFU you moron.
(disclaimer: this is an anonymous message board. Don't call people names. State your case. Step to the left. Pay your money. Otherwise... No post for you! Come back, one year!)
Click to expand...

Seems the truth hurt your feelings. Hilarious to see you call someone a moron, yet you then call someone a moron.

Think before you post next time so that you don't embarrass yourself.
 






anonymous said:
STFU you moron.
(disclaimer: this is an anonymous message board. Don't call people names. State your case. Step to the left. Pay your money. Otherwise... No post for you! Come back, one year!)
Click to expand...

Someone struck a nerve with the little child and his only comeback is to use an abbreviated profanity.

Grow up, junior.
 






Top Bottom
Back
Quote